CardiologyVideo course2026
MSKCC Cardio-Oncology Symposium 2026 — protecting the heart through cancer care
The MSKCC Cardio-Oncology Symposium 2026 was held by Memorial Sloan Kettering Cancer Center on 21–22 May 2026 at the Zuckerman Research Center in New York. Its 42 talks from 34 oncologists and cardiologists — including Alexander Lyon, Saro Armenian, Paaladinesh Thavendiranathan and Anju Nohria — pair each cancer’s treatment with its cardiac consequences: ICI myocarditis, CAR-T and transplant, lung, prostate and breast therapies, amyloidosis, thrombosis and stroke, imaging, radiation injury, cardioprotection and survivorship.
- 42talks
- 34faculty
- 2symposium days
- May 2026recorded
What you’ll be able to do
- Recognise and treat ICI myocarditis, including second-line immunosuppression
- Stratify cardiovascular risk before anthracyclines, anti-HER2, hormonal and T-cell therapies
- Use echo, CMR and biomarkers for early detection
- Manage AF, VTE and stroke in patients with cancer
- Apply permissive cardiotoxicity and cardioprotection, including dexrazoxane and exercise
- Plan follow-up for survivors of childhood cancer
Inside the course
Immunotherapy and solid tumours
The evolving field, antitumour immunity, ICI toxicity and a myocarditis case spectrum; then lung, prostate and breast cancer — each with an oncologist’s treatment primer followed by a cardiologist’s approach to its toxicity — and training pathways in cardio-oncology.
MSKCC Cardio-Oncology Symposium 2026 haematology and amyloid sessions
Stem cell and bone marrow transplant, CAR-T and bispecifics and their cardiac effects, myeloma and AL amyloid, diagnosing cardiac amyloidosis and managing TTR disease, then cancer-associated VTE and stroke.
Precision cardio-oncology and imaging
Defining risk and surveillance, a decade of key trials, precision echo and CMR, biomarkers, MR of cardiac masses, AF in cancer and device management during radiation and MRI.
Radiation, survivorship and complex care
Radiation-induced heart disease and ways to limit it, late cardiotoxicity, clonal hematopoiesis, pharmacologic and exercise cardioprotection, equity, the ESC guidelines, advanced heart failure, 5FU chest pain, interventions during active cancer and three closing cases.
Built for
- Cardiologists and cardio-oncologistsA comprehensive, current curriculum from a leading cancer centre.
- Oncologists and haematologistsHow their therapies affect the heart and when to involve cardiology.
- Internists, APPs and nursesPractical surveillance and management guidance.
Faculty & syllabus
Talks and faculty 42 talks
- Jennifer Liu, MD — Setting the Stage: The Evolving Landscape of Cardio-Oncology
- James Smithy, MD — Fundamentals of Antitumor Immunity and Current Applications in Solid Tumors
- Alexander Lyon, MA, BM, BCh, PhD — Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Current Approaches and New Frontiers
- Carol Chen, MD, Marie-Claude Beaulieu, MD — Case Discussion: The Spectrum of ICI Myocarditis – Clinical Lessons from Mild to Fulminant Presentations
- Helena Yu, MD — Updates on Contemporary Lung Cancer Diagnosis and Treatment: A Primer for the Non-Oncologist
- Anthony F Yu, MD — Cardiovascular Considerations Associated with Lung Cancer Treatment: Screening, Diagnosis, and Management
- Karen Autio, MD — Contemporary Management of Prostate Cancer: Hormonal Therapy, Radiation and Surgery – What Factors Influence Treatment Decisions?
- Krishan K Sharma, MD, MS — Screening and Managing Treatment-Related Cardiotoxicity
- Chau Dang, MD — Contemporary Breast Cancer Treatment: From Anti-HER2 Therapy to Beyond
- Anthony F Yu, MD — Cardiovascular Toxicities in Modern Breast Cancer Therapy: Updates on Screening and Management
- Dipti Gupta, MD, MPH — How to Train in Cardio-Oncology: Cardio-Oncology Fellowship Programs
- Brian Shaffer, MD — Understanding Stem Cell/Bone Marrow Transplant: When, for Whom and Why?
- Daniel Addison, MD — Cardiovascular Challenges During and After Bone Marrow Transplant: Mitigating Risk and Optimizing CV Health
- Miguel Perales, MD — Advances in T-Cell Therapies for Hematologic Cancers: CAR T, Bispecific Antibodies, and Beyond
- Eric H Yang, MD — T-Cell Immunotherapies and the Heart: Risks, Detection, and Management
- Heather J Landau, MD — Multiple Myeloma and AL Amyloidosis: A Primer on Diagnosis and Management
- Richard Cheng, MD — Cardiac Amyloidosis: Unmasking the Great Masquerader – When to Suspect, How to Diagnose
- Daniel McDonald, MD — Managing Patients with TTR Amyloidosis: Progress and Challenges
- Jeffrey Zwicker, MD — Venous Thromboembolism in Cancer Patients: Risk Assessment, Prevention and Treatment
- Babak Navi, MD — Cancer-Associated Stroke: Etiology, Detection, and Management
- Michael Fradley, MD — International Cardio-Oncology Society: Opportunities for Collaboration, Research, and Education
- Saro Armenian, DO, MPH — Laying the Foundation for Precision Cardio-Oncology: Defining Risk, Outcomes, and Surveillance
- Alexander Lyon, MA, BM, BCh, PhD — A Decade in Review: Top Research Studies and Clinical Trials in Cardio-Oncology
- Paaladinesh Thavendiranathan, MD, SM — Precision Imaging in Cardio-Oncology: Leveraging Echo and CMR for Risk Stratification and Early Detection
- Joshua D Mitchell, MD, MSCI — Biomarkers in Risk Prediction and Diagnosis
- Jonathan Weinsaft, MD — MR Imaging of Cardiac Masses: Clinical Applications and Prognostic Implications
- Michael Fradley, MD — Atrial Fibrillation and Cancer: Pathophysiology and Management Algorithm
- Michael Fradley, MD — Management of Cardiac Implantable Devices During Radiation, MRI, and Emerging Treatment Modalities
- Joshua D Mitchell, MD, MSCI — Radiation Induced Heart Disease: A Practical Guide to Diagnosis and Management
- Lior Braunstein, MD — Radiation Therapy: Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity
- Anju Nohria, MD, MS — Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer: Incidence, Risk Factors, and Individual CV Risk Prediction
- Saro Armenian, DO, MPH — Clonal Hematopoiesis: Redefining Cardiovascular Risk in Oncology and Beyond
- Anita Deswal, MD, MPH — Pharmacologic Cardioprotection in Oncology: GDMT and Beyond?
- Jessica Scott, PhD — Exercise as Cardioprotection in Oncology: From Evidence to Clinical Practice
- Michelle Johnson, MD, MPH — Cardio-Oncology Care and Health Equity: Challenges and Opportunities
- Teresa Lopez-Fernandez, MD — 2022 ESC Cardio-Oncology Guidelines: Where We Go From Here
- Jayant Raikhelkar, MD — Advanced HF Management in Cardio-Oncology
- Stephanie Feldman, MD — 5FU Induced Chest Pain: Diagnostic and Management Algorithm
- Dmitriy Feldman, MD — Navigating Cardiac Interventions in Patients with Active Cancer: Insights from Evidence and Experience
- Anthony F Yu, MD — Case 1: Dexrazoxane for Cardioprotection
- Jennifer Liu, MD — Case 2: Permissive Cardiotoxicity
- Dipti Gupta, MD, MPH — Role of Second-Line Immunosuppressants in ICI Myocarditis: When and for Whom?
Before you buy
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Course videos |
|---|---|
| Contents | 42 talks · 34 faculty |
| Recorded | 21–22 May 2026, New York |
| Publisher | Memorial Sloan Kettering Cancer Center |
| Department | Cardiology |
| Delivery | Instant download · lifetime re-download |
Related products
Anesthesiology
